MPLX LP MPLX
NYSE · XNYS · stock · Pipe Lines (No Natural Gas)
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $13.0B | — | — | $4.1B | — |
| 2024 | $9.2B | — | — | $4.9B | — |
| 2023 | $11.3B | $3.9B | — | $4.5B | — |
| 2022 | $11.6B | $3.9B | — | $4.2B | — |
| 2021 | $10.0B | $3.1B | — | $4.4B | — |
| 2020 | $7.6B | -$720.0M | — | $3.3B | — |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Walker Ray N JR | director | 2026-05-15 | Grant | 78 | — |
| SURMA JOHN P | director | 2026-05-15 | Grant | 1,656 | — |
| STICE J MICHAEL | director | 2026-05-15 | Grant | 1,098 | — |
| SEMPLE FRANK M | director | 2026-05-15 | Grant | 1,194 | — |
| Peiffer Garry L. | director | 2026-05-15 | Grant | 1,304 | — |
| HELMS CHRISTOPHER A | director | 2026-05-15 | Grant | 1,415 | — |
| Breves Christine S | director | 2026-05-15 | Grant | 277 | — |
| Walker Ray N JR | director | 2026-04-30 | Grant | 2,247 | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0001552000 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.